Cold News and Research

RSS

Salk Study Identifies Brain Signaling Target to Prevent Cancer Cachexia

According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle and fat loss, reducing quality of life and sometimes even limiting treatment options.

3 Jul 2026

Scripps Scientists Find Key Vulnerability in Drug-Resistant Enterococcus Strains

Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone.

30 Jun 2026

Advanced Bladder Cancer Spatial Mapping Identifies Diverse Cellular Tumor States

Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder cancer, revealing how tumor cell states, immune environments and therapeutic vulnerabilities are organized within tumors.

19 Jun 2026

Laverock Therapeutics Reports Key Oncology Research Milestones

Laverock Therapeutics, a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced key in-vivo functional milestones across its T-cell and macrophage oncology program for solid tumor indications.

From Laverock Therapeutics 11 Jun 2026

Scientists Decode How T Cells Stop Deadly Viruses

T cells are among the immune system’s essential soldiers. They can inhibit tumor development and even combat serious infections.

3 Jun 2026

Heatwave: Extreme Heat and Air Pollution May Worsen Migraines, New Study Finds

Migraine is a moderate to severe headache disorder with unique characteristics that distinguish it from a regular headache. It is typically described as a throbbing pain, often on one side of the head.

30 May 2026

Scientists Capture Live-Action Footage of Housekeeping Immune Cells Engulfing Melanoma

Scientists at the Garvan Institute of Medical Research have captured, for the first time, 'housekeeping' immune cells actively attacking and engulfing live melanoma cells – a discovery that could change the way we approach treatment for one of Australia's most common and deadly cancers.

22 May 2026

Polymer Platforms Help Focus Immune Attack on Cancerous Tumors

Conventional immune checkpoint inhibitors, such as anti-PD-1/PD-L1 and anti-CTLA-4 antibodies, can reinvigorate T cells but typically benefit less than 30% of patients.

21 May 2026

Animals Adapt Rapidly Through Protein Networks, Not Genes

UT Southwestern Medical Center researchers have discovered a key molecular mechanism that allows animals to adapt to changing environmental conditions without altering their genes – an ability known as phenotypic plasticity.

15 May 2026

Heat-Stable Malaria Vaccine That Stops Spread By Mosquitoes

More than half a million people die from malaria each year, but a new vaccine is showing promise since it not only provides powerful, long-lasting protection but also prevents mosquitoes from spreading the disease.

13 May 2026

Promising New Hanta Virus Vaccine Under Development by University of Bath Researchers

A highly promising vaccine for Hanta virus is being developed by researchers from the University of Bath. The team is led by Professor Asel Sartbaeva, Chemistry researcher at the University and co-founder of University spinout company Ensilitech.

8 May 2026

Singing Mice Reveal Simple Brain Changes Behind Vocal Communication

Speech is a crowning achievement of human evolution, the skill that separates us from every other animal. So, it would stand to reason that evolving this capability required some enormous leap in brain complexity.

8 May 2026

Tardigrade Proteins Allow Synthetic Cells to Survive Extreme Dehydration

A protein found only in microscopic tardigrades, one that allows them to survive extreme conditions like dehydration, can convey similar durability in synthetic cells, according to new research from University of Michigan Engineering and the University of Chicago Pritzker School of Molecular Engineering.

7 May 2026

Study Reveals How Trypanosomes Fine-Tune Protein Production Through Destruction

To survive in the human bloodstream, the African trypanosome parasite wears a "cloak" made of proteins known as a variant surface glycoprotein (VSG). The study, published in Nature Microbiology, identifies the protein that allows the parasite to fine-tune this "cloak".

31 Mar 2026

Sweat Peptide Dermcidin Prevents Flu Virus Entry Into Cells

A research team led by the Fisabio Foundation has demonstrated that dermcidin, an antimicrobial peptide produced constitutively by the human body, also exhibits antiviral activity against the influenza virus. The study also shows that people who do not develop flu-like symptoms have higher baseline levels of this molecule, which could be associated with lower susceptibility to infection.

31 Mar 2026